Page last updated: 2024-08-26

mci 9038 and Weight Gain

mci 9038 has been researched along with Weight Gain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Copple, BL; Cui, W; Kassel, KM; Luyendyk, JP; Sullivan, BP	1

Other Studies

1 other study(ies) available for mci 9038 and Weight Gain

Article	Year
Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease. The American journal of pathology, 2012, Volume: 181, Issue:4 Topics: Animals; Arginine; Chemokine CCL2; Chemokine CXCL2; Collagen; Diet; Fatty Liver; Feeding Behavior; Gene Expression Regulation; Inflammation; Intercellular Adhesion Molecule-1; Lipid Metabolism; Lipids; Liver; Liver Cirrhosis; Macrophages; Male; Mice; Mice, Inbred C57BL; Neutrophils; Pipecolic Acids; Receptors, LDL; RNA, Messenger; Sulfonamides; Thrombin; Weight Gain	2012

Article

Year

Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.

The American journal of pathology, 2012, Volume: 181, Issue:4

Topics: Animals; Arginine; Chemokine CCL2; Chemokine CXCL2; Collagen; Diet; Fatty Liver; Feeding Behavior; Gene Expression Regulation; Inflammation; Intercellular Adhesion Molecule-1; Lipid Metabolism; Lipids; Liver; Liver Cirrhosis; Macrophages; Male; Mice; Mice, Inbred C57BL; Neutrophils; Pipecolic Acids; Receptors, LDL; RNA, Messenger; Sulfonamides; Thrombin; Weight Gain

2012